Media Contact:
Alexandra Mullane
Marketing & Communications Coordinator
Phone: 212.701.3967
Fax: 212.378.2410
amullane@cahill.com

Firm News

Cahill Represents Lead Arrangers in $1.5 Billion Amended Credit Facilities for Catalent Pharma Solutions Inc.

Date: 05/17/19

Cahill represented the lead arrangers in connection with Catalent Pharma Solutions Inc.’s $950,000,000 Term B incremental credit facility and $550,000,000 revolving credit facility. Catalent Pharma Solutions Inc. is involved in technology and development for drugs, biologics and consumer health products. Proceeds from the incremental credit facility were used for the acquisition of Paragon Bioservices, Inc., a leading viral vector development and manufacturing partner for gene therapies, general corporate purposes and to refinance existing indebtedness.

Media Contact:
Alexandra Mullane
Marketing & Communications Coordinator
Phone: 212.701.3967
Fax: 212.378.2410
amullane@cahill.com